The role of Big Pharma on the increase in the diagnosis of ADHD

<p>Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects both children and adults. In recent years, the diagnosis of ADHD has been on the rise, with many experts pointing to the role of Big Pharma in this trend.</p> <p>One of the main ways that Big Pharma has contributed to the increase in ADHD diagnosis is through the development and marketing of drugs for the condition. These drugs, such as Ritalin and Adderall, are commonly prescribed to individuals who have been diagnosed with ADHD. However, some experts argue that these drugs are over-prescribed, leading to an increase in the number of individuals who are diagnosed with the condition.</p> <p><a href="https://medium.com/the-adhd-review/the-role-of-big-pharma-on-the-increase-in-the-diagnosis-of-adhd-137073f8cb1a"><strong>Read More</strong></a></p>